Hyperglycaemic hyperosmolar state in an obese prepubertal girl with type 2 diabetes: case report and critical approach to diagnosis and therapy.
Blood Glucose
/ metabolism
Child
Diabetes Mellitus, Type 2
/ blood
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Humans
Hyperglycemic Hyperosmolar Nonketotic Coma
/ diagnosis
Insulin, Long-Acting
/ administration & dosage
Metformin
/ administration & dosage
Pediatric Obesity
/ complications
Case Report
Diabetic Ketoacidosis
Hyperglycaemic hyperosmolar state
Obese children
Type 2 Diabetes
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
18 Feb 2021
18 Feb 2021
Historique:
received:
17
09
2020
accepted:
02
02
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
5
11
2021
Statut:
epublish
Résumé
Isolated Hyperosmolar Hyperglycaemic Syndrome (HHS) is a life-threatening condition characterized by elevated serum glucose concentrations and hyperosmolality without significant ketosis. It is often described in obese adults with unknown Type 2 Diabetes (T2D), rarely in youth. In childhood the most common cause of metabolic glucose related derangement is Diabetic Ketoacidosis (DKA) in Type 1 Diabetes (T1D). Interestingly, both components can be combined with each other, thus the prevalent condition needs to be recognised implying a different therapeutic approach. In this case, we report a prepubertal Caucasian obese girl admitted for two episodes of combined HHS/DKA in order to elucidate her clinical course taking into account the current pediatric recommendations based on adult guidelines for HHS. The treatment of HHS and even more of HHS/DKA in youth is still controversial as no specific guidelines for children are available especially during the prepubertal age. The description of our case might be helpful and offer relevant points for future consensus.
Identifiants
pubmed: 33602256
doi: 10.1186/s13052-021-00983-z
pii: 10.1186/s13052-021-00983-z
pmc: PMC7891158
doi:
Substances chimiques
Blood Glucose
0
Insulin, Long-Acting
0
insulin degludec
54Q18076QB
Metformin
9100L32L2N
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Références
Diabetes Care. 2020 Feb;43(2):349-357
pubmed: 31704689
Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177
pubmed: 29900641
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
Diabetes Metab. 2008 Dec;34(6 Pt 2):649-57
pubmed: 19195626
J Pediatr. 2010 Feb;156(2):180-4
pubmed: 20105637
N Engl J Med. 2017 Apr 13;376(15):1473-1474
pubmed: 28402766
J Paediatr Child Health. 2016 Jan;52(1):80-4
pubmed: 26228354
Pediatr Diabetes. 2016 Jun;17(4):266-73
pubmed: 25951940
J Pediatr. 2011 Jan;158(1):9-14, 14.e1-2
pubmed: 21035820
J Pediatr Endocrinol Metab. 2007 Oct;20(10):1115-24
pubmed: 18051930
Diabetes Care. 2014 Nov;37(11):3124-31
pubmed: 25342831